Jenny Gross

10.9k total citations
13 papers, 928 citations indexed

About

Jenny Gross is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Jenny Gross has authored 13 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Jenny Gross's work include Cancer Genomics and Diagnostics (3 papers), Salivary Gland Disorders and Functions (2 papers) and BRCA gene mutations in cancer (2 papers). Jenny Gross is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Salivary Gland Disorders and Functions (2 papers) and BRCA gene mutations in cancer (2 papers). Jenny Gross collaborates with scholars based in United States, Netherlands and Austria. Jenny Gross's co-authors include Beth Y. Karlan, Elizabeth M. Swisher, Rochelle L. Garcia, Christopher C. Pennil, Toshiyasu Taniguchi, Wataru Sakai, Kaitlyn Wurz, Barbara M. Norquist, Scott Karlan and David T. Wong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jenny Gross

12 papers receiving 909 citations

Peers

Jenny Gross
Jenny Gross
Citations per year, relative to Jenny Gross Jenny Gross (= 1×) peers Florentia Fostira

Countries citing papers authored by Jenny Gross

Since Specialization
Citations

This map shows the geographic impact of Jenny Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Gross more than expected).

Fields of papers citing papers by Jenny Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Gross. The network helps show where Jenny Gross may publish in the future.

Co-authorship network of co-authors of Jenny Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Gross. A scholar is included among the top collaborators of Jenny Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Gross. Jenny Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Verweij, Jaap, Hans R. Hendriks, H. Zwierzina, et al.. (2019). Innovation in oncology clinical trial design. Cancer Treatment Reviews. 74. 15–20. 39 indexed citations
2.
Engler, David, Sumeet Gupta, Whitfield B. Growdon, et al.. (2012). Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome. PLoS ONE. 7(2). e30996–e30996. 31 indexed citations
3.
Cass, Ilana, Mae Zakhour, Ann E. Walts, Jenny Gross, & Beth Y. Karlan. (2012). Occult cancers at risk-reducing salpingo-oophorectomies (RRSO) in BRCA mutation carriers. Gynecologic Oncology. 125. S86–S86. 1 indexed citations
4.
Norquist, Barbara M., Kaitlyn Wurz, Christopher C. Pennil, et al.. (2011). Secondary Somatic Mutations RestoringBRCA1/2Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas. Journal of Clinical Oncology. 29(22). 3008–3015. 436 indexed citations
5.
Schummer, Michèl, Ann Green, J. David Beatty, et al.. (2010). Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection. PLoS ONE. 5(2). e9122–e9122. 20 indexed citations
6.
Mercado, Cheryl, David S. Zingmond, Beth Y. Karlan, et al.. (2010). Quality of care in advanced ovarian cancer: The importance of provider specialty. Gynecologic Oncology. 117(1). 18–22. 90 indexed citations
7.
Schummer, Michèl, Ann Green, Beth Y. Karlan, et al.. (2010). Correction: Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection. PLoS ONE. 5(4). 5 indexed citations
8.
Zhang, Lei, Hua Xiao, Scott Karlan, et al.. (2010). Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer. PLoS ONE. 5(12). e15573–e15573. 217 indexed citations
9.
Zhang, Lei, Hua Xiao, Scott Karlan, et al.. (2010). Abstract 2726: Salivary biomarkers for breast cancer detection. Cancer Research. 70(8_Supplement). 2726–2726.
10.
Scholler, Nathalie, Kimberly A. Lowe, Lindsay Bergan, et al.. (2008). Use of Yeast-SecretedIn vivoBiotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA. Clinical Cancer Research. 14(9). 2647–2655. 24 indexed citations
11.
Gross, Jenny, et al.. (1988). Smoking relapse: the role of pharmacological and behavioral factors.. PubMed. 261. 163–84. 34 indexed citations
12.
Gross, Jenny. (1986). Clinical research in cancer chemotherapy.. PubMed. 13(1). 59–65. 14 indexed citations
13.
Gross, Jenny, et al.. (1977). Relationship Between Steroid Excretion Patterns and Breast Cancer Incidence in Israeli Women of Various Origins2. JNCI Journal of the National Cancer Institute. 59(1). 7–11. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026